Cipla, Roche may now spar over Valcyte Cipla’s drug may be called Valcept Bhuma Shrivastava and C.H.Unnikrishnan Email Print font size New Delhi / Mumbai: Mumbai-based Cipla Ltd is looking to launch a cheaper copycat version of Valcyte,a patented drug from the...
Challenge to Indian patent on Roche's Valcyte by local firms _ Challenge to Indian patent on Roche's Valcyte by local firms.
FDA Tentatively Approves Ranbaxy’s Generic Valcyte FDA Tentatively Approves Ranbaxy’s Generic Valcyte.
Ranbaxy Gets Tentative Approval for Generic Valcyte Check out our free and informative ezines and sign up now Sign Up Ranbaxy Laboratories has received tentative approval from the FDA to manufacture and market valganciclovir HCl 450-mg tablets, a generic version of Roches anti-viral ...
Ranbaxy Gains Tentative Approval To Manufacture And Market Valganciclovir Hydrochloride Tablets Ranbaxy Laboratories Limited (RLL), announced recently that the company has received tentative approval from the U.S.Food and Drug Administration to manufacture and market Valganciclovir Hydrochloride Tablets, 450 mg.
Total annual...
Ranbaxy gets nod to sell generic AIDS drug 0:45 IST Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration to manufacture and market the generic version of Roche's Valcyte (valganciclovir hydrochloride Tablets, 450 mg), a drug used for...
India's Ranbaxy Gets FDA Nod for Valcyte Generic MUMBAI (Reuters) - India's Ranbaxy Laboratories Ltd said it had received tentative approval from the U.S.Food and Drug Administration for the generic version of Roche's anti-viral Valcyte, saying it believed it was the first to file...
Ranbaxy gets tentative USFDA nod for AIDS drug Our Bureau New Delhi, June 25 announced on Wednesday that the company has received tentative approval from the US Food and Drug Administration to manufacture and market generic version of Roches Valcyte used in treating patients with...
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets PRINCETON, N.J.Ranbaxy believes that it has First-to-File status on Valganciclovir tablets, thereby providing a potential of 180-days of marketing exclusivity, offering a significant opportunity in the future.
Valganciclovir HCl Tablets...
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets 'First-to-File' Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S....
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets 'First-to-File' Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S....
Ranbaxy receives tentative approval to manufacture Valganciclovir hydrochloride tablets Pharmaceutical News , announced today that the company has received tentative approval from the U.S.Food and Drug Administration to manufacture and market Valganciclovir Hydrochloride Tablets, 450 mg.
Total annual market sales for...
Ranbaxy granted FDA approval for generic Valcyte _ Ranbaxy granted FDA approval for generic Valcyte.
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets 'First-to-File' Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25, 2008 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from...
Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets PRINCETON, N.J., June 25 /PRNewswire/ -- (RLL), announced today that the company has received tentative approval from the U.S.Food and Drug Administration to manufacture and market Valganciclovir Hydrochloride Tablets, 450 mg.
Total...
Ranbaxy gets US FDA tentative nod to manufacture and market valganciclovir tabs Ranbaxy Laboratories Limited (RLL) has received tentative approval from the US Food and Drug Administration (FDA) to manufacture and market valganciclovir hydrochloride tablets, 450 mg.Total annual market sales for valganciclovir HCl...
